Kidney Carcinoma

• CLINICAL_TRIALS trial_result · 2022-06-22
  Clinical Trial Update: Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer [Phase 2]

  Phase 2 trial investigating image-guided hypofractionated radiation therapy with nelfinavir mesylate and PD-1/PD-L1 inhibitors in advanced m…

• CLINICAL_TRIALS trial_result · 2017-06-07
  Clinical Trial Update: Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer [Phase 2]

  Phase 2 trial evaluating MK2206 (Akt inhibitor) or everolimus in refractory kidney cancer; study terminated with results posted in 2017.